---
$id: https://graph.org.ai/products/commodity/51241124
$type: Product
source: UNSPSC
code: "51241124"
title: "Pirnabin or pirnabine"
class: "51241100"
classTitle: "Ophthalmic agents"
family: "51240000"
familyTitle: "Drugs affecting the ears, eye, nose and skin"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Pirnabin or pirnabine

**UNSPSC Code**: 51241124
**Class**: [Ophthalmic agents](Ophthalmic agents.mdx)
**Family**: [Drugs affecting the ears, eye, nose and skin](../Drugs affecting the ears, eye, nose and skin.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anti-glaucoma agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S3FHL03F60. European Medicines Agency schedules Pirnabin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09926MIG. Pirnabin generally arises in the molecular formula C19H24O3. The term PIRNABIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 33, no. 10 1979, list 19.) PIRNABIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Pirnabin or pirnabine bears US NLM identifiers UMLS ID C3272437 and NCI Concept Code C95917. SMILES: O1C(C2=C(CC(CC2)C)C2C1CC(CC2OC(=O)C)C)(C)C.

